BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026

  March 20, 2026

   · 

  3 min read
• Press Releases

  Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

  March 20, 2026

   · 

  13 min read
• Press Releases

  Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

  March 20, 2026

   · 

  9 min read
• 

  Spinal muscular atrophy

  Roche Ends Run for Muscular Atrophy Drug, Leaving Door Open for Competitors

  The main beneficiary of Roche’s discontinuation of an investigational spinal muscular atrophy drug is Scholar Rock, which was hobbled by manufacturing concerns at a Novo Nordisk facility last year but is now nearing a potential resolution.

  March 20, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Arch Biopartners Announces St. Michael’s Hospital Commences Patient Dosing in the Phase II CS-AKI Trial of LSALT Peptide

  March 20, 2026

   · 

  10 min read
• Press Releases

  Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT

  March 20, 2026

   · 

  16 min read
• Press Releases

  Sironax Announces Upcoming Poster Presentation on NAMPT Activation

  March 20, 2026

   · 

  1 min read
• Press Releases

  Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

  March 20, 2026

   · 

  7 min read
• Press Releases

  Cardiff Oncology to Host Key Opinion Leader Discussion Focusing on First-Line RAS-mutated Metastatic Colorectal Cancer

  March 20, 2026

   · 

  3 min read
• Press Releases

  Newron to Present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

  March 20, 2026

   · 

  5 min read